Menu

Sleep Protection

Inducing certain brain patterns extends non-REM sleep in mice.

Mar 1, 2013
Kerry Grens

EDITOR'S CHOICE IN MOLECULAR BIOLOGY

HIT THE SNOOZE BUTTON: Researchers stimulate deeper sleep by optogenetically triggering certain patterns of brain activity in mice.© VALERIE LOISELEUX/ISTOCKPHOTO.COM

The paper
A. Kim et al., “Optogenetically induced sleep spindle rhythms alter sleep architectures in mice,” PNAS, 109:20673-78, 2012.

The finding
Sleep spindles are EEG-detected oscillations in brain activity, lasting from 0.5 to 3 seconds, that occur during non-REM sleep. Earlier work had proposed that neurons generating sleep-spindle patterns might help maintain sleep, as studies tied increased sleep-spindle frequency to hypersomnia, or extended periods of sleep. But these were only correlations. Now, Hee-Sup Shin of the University of Science and Technology in Daejeon, Korea, and colleagues have shown for the first time that sleep spindles in fact are responsible for maintaining longer periods of non-REM sleep.
 
The technique
Shin’s group used optogenetics—a technique that activates selected neurons via a genetically inserted light receptor called channelrhodopsin2—to induce sleep spindles in mice. The researchers inserted the light-sensitive receptor into neurons in the region of the brain that generates the spindles and shone timed light flashes to initiate the sleep spindle rhythms. “It’s a really good example of the use of this relatively new technique,” says Stuart Fogel, a postdoctoral researcher at the University of Montreal.

The sleep
The induction of sleep spindles extended the length of time the mice spent in non-REM sleep, “at the expense of waking,” says Shin. “In other words, they sleep more than the control groups.” REM sleep was unaffected by the optogenetic intervention.

The implications
Shin’s team concludes that sleep spindles protect sleep from disruption, making spindles an appealing target for the development of therapeutics. But such work is a long way off, and the researchers are focusing instead on examining other potential benefits related to sleep-spindle patterns, such as the memory consolidation essential for long-term memory.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.